Since 2001, Novartis has delivered more than 800 million Coartem anti-malaria treatments without profit to more than 60 malaria-endemic countries, mainly for public sector use. Hans Rietveld, Director of Global Access & Marketing, Malaria Initiative at Novartis AG, discussed how business made such a huge impact at a London Business School event. The speech was part of the LBS Photography Awards. To find out more about the Awards: Subscribe on YouTube: Follow on Twitter:
